Abigail Brown

Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome

Long COVID: major findings, mechanisms and recommendations

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity

Characterization of Post–exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?

Minimum data elements for research reports on CFS

Sofosbuvir: A Review of its Use in Patients with Chronic Hepatitis C

Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model

No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome

Coverage of CFS within U.S. Medical Schools

Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology

COVID-19 symptoms over time: comparing long-haulers to ME/CFS

Saliva fatigue biomarker index as a marker for severe myalgic encephalomyelitis/chronic fatigue syndrome in a community based sample

The Development of a Revised Canadian Myalgic Encephalomyelitis Chronic Fatigue Syndrome Case Definition

Measuring substantial reductions in functioning in patients with chronic fatigue syndrome

Defining Essential Features of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome

Data mining: comparing the empiric CFS to the Canadian ME/CFS case definition

Problems in Defining Post-Exertional Malaise

Cognitive impairments associated with CFS and POTS

Energy conservation/envelope theory interventions

Test–retest reliability of the DePaul Symptom Questionnaire

Are Myalgic Encephalomyelitis and chronic fatigue syndrome different illnesses? A preliminary analysis

Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis

Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis.

Chronic fatigue syndrome versus systemic exertion intolerance disease

Contrasting Case Definitions for Chronic Fatigue Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Myalgic Encephalomyelitis

Unintended Consequences of not Specifying Exclusionary Illnesses for Systemic Exertion Intolerance Disease

Case definitions integrating empiric and consensus perspectives

Reflections on the Institute of Medicine’s systemic exertion intolerance disease

Sensitivity and Specificity of the CDC Empirical Chronic Fatigue Syndrome Case Definition

Examining the energy envelope and associated symptom patterns in chronic fatigue syndrome: does coping matter?

Fatigue Scales and Chronic Fatigue Syndrome: Issues of Sensitivity and Specificity

Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome

A Constructive Debate With the CDC on the Empirical Case Definition of Chronic Fatigue Syndrome

Meta-analysis investigating post-exertional malaise between patients and controls

P1119 EARLY VIRAL KINETICS DO NOT PREDICT TREATMENT OUTCOME WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 24 WEEKS IN HCV GENOTYPE 2/3 PATIENTS IN THE VALENCE TRIAL